Vanderbilt University purchased a new stake in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 35,899 shares of the real estate investment trust's stock, valued at approximately $1,316,000.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in OHI. GAMMA Investing LLC raised its holdings in shares of Omega Healthcare Investors by 4,248.2% in the 1st quarter. GAMMA Investing LLC now owns 174,102 shares of the real estate investment trust's stock valued at $6,630,000 after purchasing an additional 170,098 shares in the last quarter. Rhumbline Advisers raised its stake in Omega Healthcare Investors by 2.7% during the 1st quarter. Rhumbline Advisers now owns 797,469 shares of the real estate investment trust's stock worth $30,368,000 after acquiring an additional 20,710 shares in the last quarter. NBC Securities Inc. acquired a new stake in Omega Healthcare Investors during the 1st quarter worth $29,000. Merit Financial Group LLC raised its stake in Omega Healthcare Investors by 27.9% during the 1st quarter. Merit Financial Group LLC now owns 43,594 shares of the real estate investment trust's stock worth $1,660,000 after acquiring an additional 9,519 shares in the last quarter. Finally, RFG Advisory LLC acquired a new stake in Omega Healthcare Investors during the 1st quarter worth $1,161,000. Hedge funds and other institutional investors own 65.25% of the company's stock.
Omega Healthcare Investors Stock Down 1.7%
OHI stock opened at $41.60 on Friday. Omega Healthcare Investors, Inc. has a 52 week low of $35.04 and a 52 week high of $44.42. The company has a market cap of $12.27 billion, a P/E ratio of 25.68, a P/E/G ratio of 2.22 and a beta of 0.70. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The company's 50-day moving average price is $41.38 and its 200 day moving average price is $38.68.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $235.60 million for the quarter, compared to the consensus estimate of $248.49 million. During the same quarter in the prior year, the firm earned $0.71 earnings per share. The company's revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, research analysts expect that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current fiscal year.
Omega Healthcare Investors Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 6.4%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is 165.43%.
Wall Street Analysts Forecast Growth
A number of research analysts have commented on OHI shares. Cantor Fitzgerald started coverage on shares of Omega Healthcare Investors in a research note on Wednesday. They issued an "overweight" rating and a $50.00 price objective on the stock. Raymond James Financial restated an "outperform" rating on shares of Omega Healthcare Investors in a research note on Tuesday, September 2nd. Royal Bank Of Canada lifted their price objective on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research note on Thursday, August 7th. Truist Financial lifted their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a report on Wednesday, September 3rd. Finally, Mizuho lifted their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a report on Thursday, September 11th. Six research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $44.44.
Read Our Latest Stock Report on Omega Healthcare Investors
Insider Activity
In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the company's stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the sale, the director owned 18,654 shares of the company's stock, valued at $749,144.64. This represents a 11.82% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is owned by company insiders.
About Omega Healthcare Investors
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.